Diferencia entre revisiones de «Otonomy s Ear Infection Drug Succeeds In Late-stage Trial»

De Wikis2i
Saltar a: navegación, buscar
(Página creada con «Jan 5 (Reuters) - Drug developer Otonomy Inc said on Thursday its drug to treat acute otitis externa (AOE), [http://vtr.org.vn/gioi-thieu-am-thuc-dai-loan-tai-viet-nam-lan...»)
 
m
Línea 1: Línea 1:
Jan 5 (Reuters) - Drug developer Otonomy Inc said on Thursday its drug to treat acute otitis externa (AOE),  [http://vtr.org.vn/gioi-thieu-am-thuc-dai-loan-tai-viet-nam-lan-thu-nhat.html vtr.org.vn] an infection in the outer ear canal,  [http://vtr.org.vn/gioi-thieu-am-thuc-dai-loan-tai-viet-nam-lan-thu-nhat.html tour đài loan giá rẻ] met the main goal in a late-stage trial.<br><br>The drug, Otiprio, is approved for [http://vtr.org.vn/3-dia-diem-khong-the-bo-qua-khi-den-tour-du-lich-dai-loan.html tour đài loan từ hà nội] use in pediatric patients during tympanostomy tube placement [http://browse.deviantart.com/?q=surgery surgery].<br><br>The company said it would submit a supplemental marketing [http://www.techandtrends.com/?s=approval%20application approval application] with the U.S. Food and Drug Administration in the first half of 2017. (Reporting by Divya Grover in Bengaluru; Editing by Shounak Dasgupta)
+
Jan 5 (Reuters) - Drug developer Otonomy Inc said on Thursday its drug to treat acute otitis externa (AOE), an infection in the [http://www.Exeideas.com/?s=outer%20ear outer ear] canal,  [http://vtr.org.vn/3-dia-diem-khong-the-bo-qua-khi-den-tour-du-lich-dai-loan.html vtr.org.vn] met the main goal in a late-stage trial.<br><br>The drug,  [http://vtr.org.vn/gioi-thieu-am-thuc-dai-loan-tai-viet-nam-lan-thu-nhat.html tour đài loan giá rẻ] Otiprio,  [http://vtr.org.vn/3-dia-diem-khong-the-bo-qua-khi-den-tour-du-lich-dai-loan.html tour đài loan giá rẻ] is approved for use in pediatric patients during tympanostomy tube [http://Www.renewableenergyworld.com/_search?q=placement placement] surgery.<br><br>The company said it would submit a supplemental marketing approval application with the U.S. Food and Drug Administration in the first half of 2017. (Reporting by Divya Grover in Bengaluru; Editing by Shounak Dasgupta)

Revisión del 14:54 23 abr 2019

Jan 5 (Reuters) - Drug developer Otonomy Inc said on Thursday its drug to treat acute otitis externa (AOE), an infection in the outer ear canal, vtr.org.vn met the main goal in a late-stage trial.

The drug, tour đài loan giá rẻ Otiprio, tour đài loan giá rẻ is approved for use in pediatric patients during tympanostomy tube placement surgery.

The company said it would submit a supplemental marketing approval application with the U.S. Food and Drug Administration in the first half of 2017. (Reporting by Divya Grover in Bengaluru; Editing by Shounak Dasgupta)